VENTURE CAPITAL

Boston Scientific

Venture capital firm tracking 1 AI investment, with focus on Drug Discovery and US startups. Total tracked deal flow: $1.5B.

📊

Portfolio

💸

Total deal flow

$1.5B

🦄

Unicorns

📅

Tracked deals

Sector focus

By portfolio category

By portfolio HQ

1 latest

Date	Startup	Round	Amount	Role
May 24, 2026	MiRus	Other	$1.5B	LEAD

1 tracked

Revolutionizing medicine with safer, more durable implants and less invasive surgeries using proprietary Rhenium-based alloy MoRe®.